|
Jan 12
|
Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
|
|
Jan 9
|
Merck (MRK) to Strengthen Cancer Pipeline With Harpoon Buyout
|
|
Jan 9
|
Merck Is in Advanced Talks to Buy Cancer Drugmaker Harpoon Therapeutics
|
|
Dec 19
|
Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium
|
|
Dec 8
|
Harpoon Ventures Raises $125 Million for Early-Stage Startups
|
|
Dec 6
|
ImmunoGen (IMGN) Gets FDA Priority Review for Elahere sBLA
|
|
Dec 5
|
Harpoon Therapeutics, Inc. (HARP) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Dec 5
|
Best Momentum Stock to Buy for December 5th
|
|
Nov 30
|
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
|
|
Nov 30
|
Wall Street Analysts Believe Harpoon Therapeutics, Inc. (HARP) Could Rally 40.5%: Here's is How to Trade
|
|
Nov 15
|
Fast-paced Momentum Stock Harpoon Therapeutics, Inc. (HARP) Is Still Trading at a Bargain
|
|
Nov 14
|
Wall Street Analysts See a 92.31% Upside in Harpoon Therapeutics, Inc. (HARP): Can the Stock Really Move This High?
|
|
Nov 2
|
Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition
|
|
Sep 6
|
Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting
|
|
Sep 5
|
Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023
|
|
Sep 5
|
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September
|
|
Aug 9
|
Harpoon Therapeutics, Inc. (HARP) Beats Q2 Earnings and Revenue Estimates
|
|
Aug 9
|
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|